ArticleHaematologica2025

Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow-up.

Andrew J Portuguese et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.